Genetic variation in F3 (tissue factor) and the risk of incident venous thrombosis: meta‐analysis of eight studies
Year: 2012
Type: article
Study design: Systematic Review
Institutions: Group Health Cooperative, Kaiser Permanente Washington Health Research Institute, University of Washington, VA Office of Research and Development, Seattle Epidemiologic Information and Research Center, Mayo Clinic, University of Minnesota, University of Minnesota, Duluth, Erasmus MC, Erasmus University Rotterdam, Brigham and Women's Hospital, Harvard University, Inserm, Aix-Marseille Université
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
Funders: Donald W. Reynolds Foundation, Amgen, Sanofi, Mayo Foundation for Medical Education and Research, European Commission, Fondation Leducq, Institut National de la Santé et de la Recherche Médicale, ZonMw, Erasmus Universiteit Rotterdam, Ministerie van Volksgezondheid, Welzijn en Sport, Erasmus Medisch Centrum, Ministerie van Onderwijs, Cultuur en Wetenschap, Nederlandse Organisatie voor Wetenschappelijk Onderzoek, Eisai, Fondation de France, Agence Française de Sécurité Sanitaire des Produits de Santé, Mutuelle Générale de l'Education Nationale, National Institutes of Health, U.S. Public Health Service, National Institute on Aging, National Heart, Lung, and Blood Institute, National Human Genome Research Institute, National Cancer Institute, National Institute of Diabetes and Digestive and Kidney Diseases, National Institute of Neurological Disorders and Stroke, National Center for Research Resources, National Center for Advancing Translational Sciences
Awards: G1003575363, G1028935811, GWAS of Venous Thrombosis, G1083489883, G118440752, G1220223050, G1224608327, CORONARY HEART DISEASE AND STROKE, CORONARY HEART DISEASE &STROKE IN PEOPLE AGED 65-84, G1325221871, G136105103, G1393829352, G1401438683, G1412333385, G1462415530, Estrogens and pharmacogenetic risks of venous thrombosis in postmenopausal women, CHS-ULTRASOUND READING, G1528515809, CORONARY HEART DISEASE AND STROKE, UCLA Clinical and Translational Science Institute, G1727292203, G1742450553, CORONARY HEART DISEASE AND STROKE IN PEOPLE AGED 65-84, G1885842644, G1890355377, G1909643007, G1980873071, Genome-wide case-only study of antihypertensive drug-gene interactions, Atherosclerosis Risk in Communities Study (ARIC), G2139852533, G215333750, G2189639697, G2193588257, G2194386449, CORONARY HEART DISEASE AND STROKE IN PEOPLE AGED 65-84, CORONARY HEART DISEASE &STROKE IN PEOPLE AGED 65-84, G229684361, G236442059, G2391884931, Pharmacogenetics and Cardiovascular Events, G2450915342, Exceptional Survival: Trajectories to Functional Aging (CHS All Stars), CCSP FIELD CENTER, G2555954497, G2587248622, G25881238, CORONARY HEART DISEASE &STROKE IN THE ELDERLY, G2663518188, COMMUNITY AND COHORT SURVEILLANCE PROGRAM, G274585943, G277826483, G2786044735, G2800149121, CENTRAL HEMOSTATIS LABORATORY FOR CCSP, G2847759872, G2882309788, G3045517347, WGA Study to Identify Genetic Variants Associated with CV Events in CHS, G3087775723, G3137375862, G3145043064, G3169706684, Pharmacogenomics and Risk of Cardiovascular Disease, Atrial Fibrillation: Incidence, Risk Factors, and Genetics, G3200378041, G3219722387, G3236609591, UCLA Clinical and Translational Science Institute, G333228317, G3370719899, G3507024915, G3560915123, G384035247, G3860363877, G390162502, CENTRAL BLOOD ANALYSIS LABORATORY FOR CHS, Predictors of Alheimers Disease in Mild Cognitive Impairment, G4012114008, G4145745212, G423252844, Subcortical Hyperintensities in Sleep Apnea Syndrome, Atherosclerosis Risk in Communities Study (ARIC), G4617276643, G4660668308, G4671189754, Pharmacogenomics and Risk of Cardiovascular Disease, G4747384318, G4770872528, G4932516547, MUTATIONS, HORMONE THERAPY, AND VENOUS THROMBOEMBOLISM, G4987078009, G5167412771, G528395701, G5369020747, G5451084504, G552178769, G5522185877, Epidemiology of Venous Thrombosis and Pulmonary Embolism, G558986044, Atherosclerosis Risk in Communities Study (ARIC), G573134505, G581887176, CHARGE consortium: omics discovery for CVD and aging phenotypes, CHS Events Follow-up Study, G61834786, G6203107232, G6204895930, G6226795708, Predictors of Alzheimers Disease in Mild Cognitive Impairment, G6279754272, G6361934619, Individual Propensity to Venous Thrombosis, G6576172577, G6832344490, G6860406196, G687544517, TRIAL OF ASPIRIN AND VITAMIN E IN WOMEN, G693548699, ANTIHYPERTENSIVE DRUG/GENE INTERACTIONS AND CV EVENTS, G7007046788, G7035200923, G7176672723, G7364523043, G7453254864, CHS RETINAL READING CENTER, G764651519, G766700449, G766843672, Exceptional Survival: Trajectories to Functional Aging (CHS All Stars), G7693351332, G77250574, G777822606, CHS Events Follow-up Study, G786153652, Women's Health Study: Continued Follow-up, G793702358, G7962241407, G7999488110, G806768229, G812579647, G8276458029, G8402048158, G8472450595, G8486527673, COGNITIVE TESTS, APOE, BRAIN MRI AND RISKS OF DEMENTIA, G8546760883, Pharmacologic and pharmacogenetic associations with recurrent venous thrombosis, G8593276544, G859984287, CHS-Transition Phase -268055222, Hormonal trajectories in aging, G9000015747, G9000027259, G9000028264, G9000058182, G9000065537, G9000069887, G9000080822, G9000108254, G9000126117, G9000140433, G9000143860, G9000145448, G9000152345, G9000155493, G9000159977, G9000239991, G9000294005, G9000294209, G9000332794, Diabetes Research Center (DRC), G905887895, G947029668, G960597250, Atherosclerosis Risk in Communities Study (ARIC)
OpenAlex ID: W1534155119